v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
 Net cash provided by (used in): Operating activities      
Net loss for the period $ (14,330,492) $ (5,011,239)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accretion 16,749 14,861
Depreciation 140,517 106,305
Stock-based compensation 1,149,691 354,117
Non-cash lease expenses 24,441 30,416
Changes in operating assets and liabilities    
Inventories (111,342) 20,138
Prepaid expenses (90,650) (336,447)
Other receivables 50,346 (4,969)
Accounts payable 252,074 (144,967)
Accrued liabilities 162,537 302,269
Lease liabilities (28,100) (27,118)
Net cash used in operating activities (12,764,229) (4,696,634)
Investing activities    
Purchase of equipment (481,182)
Net cash used in investing activities (481,182)
Financing activities    
Proceeds from At-The-Market offering, net of issuance costs 1,228,046 4,062,395
Proceeds from common shares issued upon exercise of warrants 1,700,699
Proceeds from registered direct offering 4,000,001
Net cash provided by financing activities 6,928,746 4,062,395
Net change in cash, cash equivalents and restricted cash (6,316,665) (634,239)
Cash, cash equivalents and restricted cash, beginning of period 7,420,797 3,967,008
Cash, cash equivalents and restricted cash, end of period $ 1,104,132 $ 3,332,769